LS
Leffler Scott J.
首席财务官
OtherM
内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Leffler Scott J., 首席财务官. Director active across 3 companies, notably Sotera Health Co. Cumulatively, 12 disclosures have been recorded. Activity tracked since 20 November 2021. The latest transaction was disclosed on 13 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Leffler Scott J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
72,165 股0Common StockSEC:0001628280-25-013143:0
12,230 股@ US$12.54100.0% 占其流量Common StockSEC:0001832406-25-000002:0
46,905 股0Common StockSEC:0001832406-24-000003:0
46,095 股0Common StockSEC:0001628280-24-011679:0
117,770 股0Common StockSEC:0001628280-24-002452:0
83,538 股@ US$0.9813.3% 占其流量Class A Common StockSEC:0001801170-24-000049:0
400,000 股0Class A Common StockSEC:0001801170-23-000092:0
124,002 股@ US$0.9118.9% 占其流量Class A Common StockSEC:0001801170-23-000070:0
387,173 股@ US$1.0967.7% 占其流量Class A Common StockSEC:0000895345-23-000420:0
5,042,016 股0Class A Common StockSEC:0001832406-22-000005:0
37,443 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-22-000020:0
3,894 股@ US$22.54100.0% 占其流量Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-21-000077:0
About Leffler Scott J.
Leffler Scott J. is Chief Financial Officer and Treasurer. His 12 filings cover attribution-related entries at Myriad Genetics INC, Clover Health Investments, CORP. /de and Sotera Health Co, and across the 12 sampled filings the period runs from 2021-11-23 to 2025-03-17, with sum_buy_eur at 0 and sum_sell_eur at 0.